| Anti-Infective
Agents in Medicinal Chemistry
(Formerly 'Current Medicinal Chemistry - Anti-Infective
Agents')
ISSN: 1871-5214 - Volume 7, 4 Issues, 2008

Editor-in-Chief:
Mark L. Nelson
Paratek Pharmaceuticals Inc.
75 Kneeland Street, 5th Floor
Boston, MA 02111
USA
Tel: 617-275-0040 (ext 202)
E-mail: mnelson@Paratekpharm.com
Editorial Advisory Board:
T. Abe (Meiji Seika Kaisya
LTD, Kanagawa, Japan)
N.E. Allen (Indiana Univ. Sch. of Med., Indianapolis,
IN, USA)
R. Andersen (University of British Columbia,
Vancouver, Canada)
A. Angelova (Université de Paris-Sud,
Chatenay-Malabry, France)
M.A. Avery (University of Mississippi, Mississippi,
MS, USA)
S. Batra (CDRI, Lucknow, India)
J.-B. Behr (Université de Reims Champagne
Ardenne, Reims, France)
C.A. Bewley (National Institutes of Health,
Bethesda, MD, USA)
C. Biot (Universite Libre de Bruxelles, Bruxelles,
Belgium)
K. Brandenburg (Forschungszentrum Borstel,
Borstel, Germany)
R. Bucki (University of Pennsylvania, Philadelphia,
PA, USA)
J.D. Buynak (Southern Methodist University,
Dallas, TX, USA)
M. Caraglia (National Institute of Tumours
Fondazione G. Pascale, Naples, Italy)
L. Chan (ViroChem Pharma Inc., Laval, Quebec,
Canada)
D. Craik (University of Queensland, Brisbane,
Australia)
P. Cravo (Centro de Malária e Outras
Doenças Tropicais, Lisboa, Portugal)
R. Dolcetti (C.R.O. National Cancer Institute,
Aviano, Italy)
P. Domingo (Autonomous Univeristy of Barcelona,
Barcelona, Spain)
R. Fernandez-Lafuente (Spanish Research Council,
Madrid, Spain)
I. François (Centre of Microbial and
Plant Genetics, Heverlee, Belgium)
C. Gamazo (University of Navarra, Pamplona,
Spain)
E.L. Ghisalberti (The Univ. of Western Australia,
Perth, Australia)
J. Heitman (Duke University Medical Center,
Durham, NC, USA)
W. Hillen (Friedrich-Alexander Universität,
Erlangen, Germany)
S.-H. Huang (USC School of Medicine, Los
Angeles, CA, USA)
R.J.-R. Hwu (National Tsing Hua University,
Taipei, Taiwan)
K. Ikeda (University of Shizuoka, Shizuoka-Shi,
Japan)
S.M. Jachak (NIPER, Punjab, India)
G. Jori (University of Padova, Padova, Italy)
A.A. Joshi (Advinus Therapeutics Pvt. Ltd,
Pune, India)
M.E. Jung (University of California, Los
Angeles, CA, USA)
D. Kerboeuf (INRA, Nouzilly, France)
M. Kidwai (University of Delhi, Delhi, India)
M. Konaklieva (American University, Washington,
DC, USA)
B. Kundu (CDRI, Lucknow, India)
S.S. Lee (University of Calgary, Calgary,
Canada)
S. Levy (Tufts University School of Medicine,
Boston, MA, USA)
W. Magliani (Università degli Studi,
Parma, Italy)
T. Maisch (University of Regensburg, Regensburg,
Germany)
R. Manfredi (University of Bologna, Bologna,
Italy)
M.O. Mitchell (Salisbury University, Salisbury,
MD, USA)
P. Nordmann (University Paris Sud, Bicetre,
France)
D. Payne (GlaxoSmithKline, Collegeville,
PA, USA)
B.M. Pinto (Simon Fraser University, Burnaby,
Canada)
A.R. Renslo (University of California, San
Francisco, CA, USA)
T. Rezanka (Inst. of Microbiology, Prague,
Czech Republic)
J. Roig (University of Andorra, Andorra,
Spain)
F.J. Rojo (Instituto de Investigaciones Químicas,
Sevilla, Spain)
S. Sardari (Pasteur Institute of Iran, Tehran,
Iran)
P.B. Savage (Brigham Young University, Provo,
UT, USA)
L.M. Schang (University of Alberta, Edmonton,
Alberta, Canada)
R. Schaumann (Institute for Medical Microbiology,
Leipzig, Germany)
C.-K. Sha (National Tsing Hua University,
Hsinchu, Taiwan)
M. Shahid (Aligarh Muslim University, Aligarh,
India)
H. Thorlacius (Lund University, Lund, Sweden)
F.M.E. Wagenlehner (Justus-Liebig-University,
Giessen, Germany)
D. Yang (University of British Columbia,Vancouver,
Canada)
|